Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
As of 2026-04-13, Coherus Oncology Inc. (CHRS) trades at a current price of $1.66, marking a 1.49% decline in recent trading. This analysis focuses on key technical levels, prevailing sector trends, and potential near-term price scenarios for the oncology-focused biotech firm, as no recent earnings data is available for CHRS at the time of writing. Recent price action for CHRS has been range-bound, with limited material company-specific news driving moves, making technical levels a key point of
What should investors watch in Coherus (CHRS) Stock | Price at $1.66, Down 1.49% - Crowd Sentiment Stocks
CHRS - Stock Analysis
3372 Comments
1360 Likes
1
Antwane
Returning User
2 hours ago
This feels like something I’ll think about later.
👍 192
Reply
2
Adaley
Legendary User
5 hours ago
I was literally searching for this… yesterday.
👍 108
Reply
3
Nirvan
Active Reader
1 day ago
Real-time US stock currency and international exposure analysis for understanding global business impacts on company earnings and valuations. We help you understand how exchange rates and international operations affect your portfolio companies and their financial performance. We provide currency exposure analysis, international revenue breakdown, and forex impact modeling for comprehensive coverage. Understand global impacts with our comprehensive international analysis and exposure tools for global portfolio management.
👍 73
Reply
The market shows resilience in the face of external pressures.
👍 210
Reply
5
Beaudry
Registered User
2 days ago
Professional and insightful, well-structured commentary.
👍 10
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.